1c99f2f2 C07c 45a1 B18f 64a3ee505190 01
Clonidine Hydrochloride Tablet, Extended Release
Product Images NDC 68180-606
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Clonidine Hydrochloride (NDC 68180-606). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
1c99f2f2 C07c 45a1 B18f 64a3ee505190 02
1c99f2f2 C07c 45a1 B18f 64a3ee505190 03
This appears to be a chart showing the estimated proportion of patients experiencing treatment failure over a period of 20 days, for two different medications (Clonidine Hydrochbride and Placebo) in Extended Release Tablet form. The chart includes data points for each day of the 20-day period and seems to suggest that the medication may impact treatment failure rates in patients.*
1c99f2f2 C07c 45a1 B18f 64a3ee505190 04
Clonidine hydrochloride extended-release tablets USP 0.1 mg are a medication manufactured by Lupin Pharmaceuticals in the United States. These tablets must be swallowed whole and not chewed, crushed, or cut. The usual dosage can be found in the package insert with full prescribing information. These tablets should be stored in controlled room temperature between 15° to 30°C. Caution should be exercised to keep them out of reach of children. These tablets should not be substituted for other clonidine products. This is a prescription-only medication that comes in a pack of 30 tablets.*
1c99f2f2 C07c 45a1 B18f 64a3ee505190 05
This is a prescription medication containing clonidine hydrochloride USP 0.1mg in extended-release tablet form manufactured by Lupin Pharmaceuticals, Inc. It should not be substituted for other clonidine products and must be taken whole and never crushed, cut, or chewed. Recommended dosage information can be found in the package insert. It should be stored at 25°C (77°F) without access to children. However, the description does not provide information about the indicated uses or potential side effects.*
1c99f2f2 C07c 45a1 B18f 64a3ee505190 06
This is a description of a medication called Clonidine Hydrochloride extended-release tablets USP. It contains 0.1 mg of clonidine hydrochloride and is manufactured by Lupin Pharmaceuticals Inc. The tablets should be swallowed whole and not crushed, cut or chewed. The usual dosage and full prescribing information can be found in the package insert. The tablets should be stored at a temperature of 25°C and kept out of reach of children. It is not advised to substitute this medication with other clonidine products. This product is available in a bottle that contains 90 tablets.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
